Last update :
29/10/2024
Hormone   Levothyroxine  
Oral solution
injection
Stability of pharmaceutical preparations Stability of mixtures Factors which affect stability Compatibility References pdf
   Chemical structure  

Oral solution
Stability of pharmaceutical preparations   Oral solution   Stability of pharmaceutical preparations : Levothyroxine     
Container Origine excipient Temperature Storage Duration of stability References
plastic bottle tablets 2,5 mg
® = (Fresenius)
OraPlus® / OraSweet® (1:1) >> 100 mL
25°C Protect from light
7 Day
3811

plastic bottle tablets 2,5 mg
® = (Fresenius)
OraPlus® / OraSweet® (1:1) >> 100 mL
5°C Protect from light
14 Day
3811

Not specified tablets 1,5 mg
Eltroxin®
Glycerin
Purified water >> 100 mL
22°C Not specified
28 Day
4112

Not specified tablets 1,5 mg
® = Levothyroxine Mercuri Pharma
Glycerin
Purified water >> 100 mL
22°C Not specified
28 Day
4112

Not specified tablets 40 mg
Synthroid®
Sorbitol 70% 500 ml
Ethanol 50 ml
Glycerin 250 ml
methylparaben 1 g
Propylparaben 200 mg
propylene glycol >> 10 ml
sodium bisulfite 1g
Sodium edetate 1 g
NaH2PO4 4.768 g
Sodium phosphate 17.719 g
Banana flavor 10 ml
Purified water >> 1000 ml
25°C Not specified
15 Day
2657

Not specified tablets 1,5 mg
Eltroxin®
Glycerin
Purified water >> 100 mL
4°C Not specified
28 Day
4112

Not specified tablets 1,5 mg
® = Levothyroxine Mercuri Pharma
Glycerin
Purified water >> 100 mL
4°C Not specified
28 Day
4112

Not specified tablets 40 mg
Synthroid®
Sorbitol 70% 500 ml
Ethanol 50 ml
Glycerin 250 ml
methylparaben 1 g
Propylparaben 200 mg
propylene glycol >> 10 ml
sodium bisulfite 1g
Sodium edetate 1 g
NaH2PO4 4.768 g
Sodium phosphate 17.719 g
Banana flavor 10 ml
Purified water >> 1000 ml
5°C Not specified
47 Day
2657


  Mentions Légales